Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening
- PMID: 18573776
- DOI: 10.1258/jms.2008.007071
Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening
Abstract
Objectives: Mean sojourn time (MST) and screening test sensitivity (STS), is usually estimated by Markov models using incidence data from the first screening round and the interval between screening examinations. However, several screening programmes do not have full registration of cancers submerging after screening, and increased use of opportunistic screening over time can raise questions regarding the quality of interval cancer registration. Methods/settings Based on the earlier used Markov model, formulas for expected number of cases given time since former screening activity was developed. Using questionnaire data for 336,533 women in the Norwegian Breast Cancer Screening Programme (NBCSP), mean square regression estimates of MST and STS were calculated.
Results: In contrast to the previously used method, the new approach gave satisfactory model fit. MST was estimated to 5.6 years for women aged 50-59 years, and 6.9 years for women aged 60-69 years, and STS was estimated to 55% and 60%, respectively. Attempts to add separate parameters for breast cancer incidence without screening, or previous STS, resulted in wide confidence intervals if estimated separately, and non-identifiably if combined.
Conclusion: Previously published results of long MST and low screen test sensitivity were confirmed with the new approach. Questionnaire data on time since previous screening can be used to estimate MST and STS, but the approach is sensitive to relaxing the assumptions regarding the expected breast cancer incidence without screening and constant STS over time.
Similar articles
-
Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results.J Med Screen. 2005;12(4):172-8. doi: 10.1258/096914105775220732. J Med Screen. 2005. PMID: 16417693
-
Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer.Breast Cancer Res Treat. 2010 Jul;122(2):553-66. doi: 10.1007/s10549-009-0701-x. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054645
-
Estimating screening test sensitivity and tumour progression using tumour size and time since previous screening.Stat Methods Med Res. 2010 Oct;19(5):507-27. doi: 10.1177/0962280209359860. Epub 2010 Mar 31. Stat Methods Med Res. 2010. PMID: 20356856
-
Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft.Int J Epidemiol. 2008 Feb;37(1):36-41. doi: 10.1093/ije/dym137. Epub 2007 Jul 20. Int J Epidemiol. 2008. PMID: 17644530 Review. No abstract available.
-
The role of magnetic resonance imaging in screening women at high risk of breast cancer.Top Magn Reson Imaging. 2008 Jun;19(3):163-9. doi: 10.1097/RMR.0b013e31818bc994. Top Magn Reson Imaging. 2008. PMID: 18941396 Review.
Cited by
-
A Bayesian model for estimating multi-state disease progression.Comput Biol Med. 2017 Feb 1;81:111-120. doi: 10.1016/j.compbiomed.2016.12.011. Epub 2016 Dec 22. Comput Biol Med. 2017. PMID: 28038345 Free PMC article.
-
Adjusting the incidence increase when screening for statistical lead time will always give estimates of overdiagnosis close to zero.Breast Cancer Res. 2014 Jun 4;16(3):404. doi: 10.1186/bcr3671. Breast Cancer Res. 2014. PMID: 25928223 Free PMC article. No abstract available.
-
Noise-Driven Phenotypic Heterogeneity with Finite Correlation Time in Clonal Populations.PLoS One. 2015 Jul 23;10(7):e0132397. doi: 10.1371/journal.pone.0132397. eCollection 2015. PLoS One. 2015. PMID: 26203903 Free PMC article.
-
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis.Br J Cancer. 2013 Oct 1;109(7):2014-9. doi: 10.1038/bjc.2013.427. Epub 2013 Aug 20. Br J Cancer. 2013. PMID: 23963144 Free PMC article.
-
A new statistical method for curve group analysis of longitudinal gene expression data illustrated for breast cancer in the NOWAC postgenome cohort as a proof of principle.BMC Med Res Methodol. 2016 Mar 5;16:28. doi: 10.1186/s12874-016-0129-z. BMC Med Res Methodol. 2016. PMID: 26944545 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical